mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.002 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |